SU‐FF‐T‐267

Total Skin Electron Therapy Skin Dose Validation Using Optically Stimulated Luminescent Dosimeters

C. Esquivel, M. Smith, Sotirios Stathakis, A. Gutierrez, C. Shi, Nikos Papanikolaou

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Total Skin Electron Therapy skin dose validation using optically stimulated luminescent dosimeters Methods and Materials: The institution's standard of care for total skin electron therapy (TSE) follows the Stanford Technique on a Varian 2300 EX linac that treats the patient standing in six different positions. The patient stands 140 cm from the beam's isocenter. A 9MeV HDTSe electron beam delivers 200 cGy to the skin's surface up to a depth of 0.8 cm with a rapid drop‐off of dose. A 1.2 cm acrylic beam spoiler 30 cm was placed in front of the patient and a sheet of 1mm of aluminum is at the gantry head. Phantom measurements were made to determine suitability of optically stimulated luminescence dosimeters (OSLDs) for in vivo dosimetry of TSE patients. A 30×30×30 cm3 solid water phantom was placed at 100 cm SSD. TLDs, OSLDs and calibrated plane parallel ion chamber were placed at the center of the phantom under 2.1 cm of build up. A dose of 100 cGy was delivered for calibration. For validating the response of the OSLDs, both TLDs and OSLDs were located at different locations around the torso of a Rando phantom. Following the technique described above, the Rando phantom was irradiated to deliver a surface dose of 200 cGy. In addition, in vivo measurements were made for a TSE patient at seven different body points. Results: OSLD phantom measurements were 3% agreement with the ROOS chamber and 4.5% with TLDs during calibration. Skin dose validation of the Rando phantom between TLDs and OSLDs differed by as much as 5.6%. In vivo dosimetry using OSLDs for the patient agreed within 7% for TLDs. Conclusions: Results for both the phantom and patient measurements shows that OSLDs are suitable for in vivo dosimetry in Total Skin Electron beam therapy.

Original languageEnglish (US)
Pages (from-to)2582
Number of pages1
JournalMedical Physics
Volume36
Issue number6
DOIs
StatePublished - 2009

Fingerprint

Luminescence
Electrons
Skin
Therapeutics
Calibration
Silver Sulfadiazine
Radiation Dosimeters
Torso
Standard of Care
Aluminum
Head
Ions
Water
In Vivo Dosimetry

ASJC Scopus subject areas

  • Biophysics
  • Radiology Nuclear Medicine and imaging

Cite this

SU‐FF‐T‐267 : Total Skin Electron Therapy Skin Dose Validation Using Optically Stimulated Luminescent Dosimeters. / Esquivel, C.; Smith, M.; Stathakis, Sotirios; Gutierrez, A.; Shi, C.; Papanikolaou, Nikos.

In: Medical Physics, Vol. 36, No. 6, 2009, p. 2582.

Research output: Contribution to journalArticle

Esquivel, C. ; Smith, M. ; Stathakis, Sotirios ; Gutierrez, A. ; Shi, C. ; Papanikolaou, Nikos. / SU‐FF‐T‐267 : Total Skin Electron Therapy Skin Dose Validation Using Optically Stimulated Luminescent Dosimeters. In: Medical Physics. 2009 ; Vol. 36, No. 6. pp. 2582.
@article{cbe59c705ad944d48a737a1551a6d5aa,
title = "SU‐FF‐T‐267: Total Skin Electron Therapy Skin Dose Validation Using Optically Stimulated Luminescent Dosimeters",
abstract = "Purpose: Total Skin Electron Therapy skin dose validation using optically stimulated luminescent dosimeters Methods and Materials: The institution's standard of care for total skin electron therapy (TSE) follows the Stanford Technique on a Varian 2300 EX linac that treats the patient standing in six different positions. The patient stands 140 cm from the beam's isocenter. A 9MeV HDTSe electron beam delivers 200 cGy to the skin's surface up to a depth of 0.8 cm with a rapid drop‐off of dose. A 1.2 cm acrylic beam spoiler 30 cm was placed in front of the patient and a sheet of 1mm of aluminum is at the gantry head. Phantom measurements were made to determine suitability of optically stimulated luminescence dosimeters (OSLDs) for in vivo dosimetry of TSE patients. A 30×30×30 cm3 solid water phantom was placed at 100 cm SSD. TLDs, OSLDs and calibrated plane parallel ion chamber were placed at the center of the phantom under 2.1 cm of build up. A dose of 100 cGy was delivered for calibration. For validating the response of the OSLDs, both TLDs and OSLDs were located at different locations around the torso of a Rando phantom. Following the technique described above, the Rando phantom was irradiated to deliver a surface dose of 200 cGy. In addition, in vivo measurements were made for a TSE patient at seven different body points. Results: OSLD phantom measurements were 3{\%} agreement with the ROOS chamber and 4.5{\%} with TLDs during calibration. Skin dose validation of the Rando phantom between TLDs and OSLDs differed by as much as 5.6{\%}. In vivo dosimetry using OSLDs for the patient agreed within 7{\%} for TLDs. Conclusions: Results for both the phantom and patient measurements shows that OSLDs are suitable for in vivo dosimetry in Total Skin Electron beam therapy.",
author = "C. Esquivel and M. Smith and Sotirios Stathakis and A. Gutierrez and C. Shi and Nikos Papanikolaou",
year = "2009",
doi = "10.1118/1.3181744",
language = "English (US)",
volume = "36",
pages = "2582",
journal = "Medical Physics",
issn = "0094-2405",
publisher = "AAPM - American Association of Physicists in Medicine",
number = "6",

}

TY - JOUR

T1 - SU‐FF‐T‐267

T2 - Total Skin Electron Therapy Skin Dose Validation Using Optically Stimulated Luminescent Dosimeters

AU - Esquivel, C.

AU - Smith, M.

AU - Stathakis, Sotirios

AU - Gutierrez, A.

AU - Shi, C.

AU - Papanikolaou, Nikos

PY - 2009

Y1 - 2009

N2 - Purpose: Total Skin Electron Therapy skin dose validation using optically stimulated luminescent dosimeters Methods and Materials: The institution's standard of care for total skin electron therapy (TSE) follows the Stanford Technique on a Varian 2300 EX linac that treats the patient standing in six different positions. The patient stands 140 cm from the beam's isocenter. A 9MeV HDTSe electron beam delivers 200 cGy to the skin's surface up to a depth of 0.8 cm with a rapid drop‐off of dose. A 1.2 cm acrylic beam spoiler 30 cm was placed in front of the patient and a sheet of 1mm of aluminum is at the gantry head. Phantom measurements were made to determine suitability of optically stimulated luminescence dosimeters (OSLDs) for in vivo dosimetry of TSE patients. A 30×30×30 cm3 solid water phantom was placed at 100 cm SSD. TLDs, OSLDs and calibrated plane parallel ion chamber were placed at the center of the phantom under 2.1 cm of build up. A dose of 100 cGy was delivered for calibration. For validating the response of the OSLDs, both TLDs and OSLDs were located at different locations around the torso of a Rando phantom. Following the technique described above, the Rando phantom was irradiated to deliver a surface dose of 200 cGy. In addition, in vivo measurements were made for a TSE patient at seven different body points. Results: OSLD phantom measurements were 3% agreement with the ROOS chamber and 4.5% with TLDs during calibration. Skin dose validation of the Rando phantom between TLDs and OSLDs differed by as much as 5.6%. In vivo dosimetry using OSLDs for the patient agreed within 7% for TLDs. Conclusions: Results for both the phantom and patient measurements shows that OSLDs are suitable for in vivo dosimetry in Total Skin Electron beam therapy.

AB - Purpose: Total Skin Electron Therapy skin dose validation using optically stimulated luminescent dosimeters Methods and Materials: The institution's standard of care for total skin electron therapy (TSE) follows the Stanford Technique on a Varian 2300 EX linac that treats the patient standing in six different positions. The patient stands 140 cm from the beam's isocenter. A 9MeV HDTSe electron beam delivers 200 cGy to the skin's surface up to a depth of 0.8 cm with a rapid drop‐off of dose. A 1.2 cm acrylic beam spoiler 30 cm was placed in front of the patient and a sheet of 1mm of aluminum is at the gantry head. Phantom measurements were made to determine suitability of optically stimulated luminescence dosimeters (OSLDs) for in vivo dosimetry of TSE patients. A 30×30×30 cm3 solid water phantom was placed at 100 cm SSD. TLDs, OSLDs and calibrated plane parallel ion chamber were placed at the center of the phantom under 2.1 cm of build up. A dose of 100 cGy was delivered for calibration. For validating the response of the OSLDs, both TLDs and OSLDs were located at different locations around the torso of a Rando phantom. Following the technique described above, the Rando phantom was irradiated to deliver a surface dose of 200 cGy. In addition, in vivo measurements were made for a TSE patient at seven different body points. Results: OSLD phantom measurements were 3% agreement with the ROOS chamber and 4.5% with TLDs during calibration. Skin dose validation of the Rando phantom between TLDs and OSLDs differed by as much as 5.6%. In vivo dosimetry using OSLDs for the patient agreed within 7% for TLDs. Conclusions: Results for both the phantom and patient measurements shows that OSLDs are suitable for in vivo dosimetry in Total Skin Electron beam therapy.

UR - http://www.scopus.com/inward/record.url?scp=84895825290&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895825290&partnerID=8YFLogxK

U2 - 10.1118/1.3181744

DO - 10.1118/1.3181744

M3 - Article

VL - 36

SP - 2582

JO - Medical Physics

JF - Medical Physics

SN - 0094-2405

IS - 6

ER -